Genomic evolution in Barrett's adenocarcinoma cells: critical roles of elevated hsRAD51, homologous recombination and Alu sequences in the genome

Jagannath Pal(Dana-Farber Cancer Institute), Masood A. Shammas(Dana-Farber Cancer Institute), Donald W. Weaver(Wayne State University), Leutz Buon(Harvard University), Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Aamer Qazi(Wayne State University), Nikhil C. Munshi(Dana-Farber Cancer Institute), Samiran Bandyopadhyay(Indian Veterinary Research Institute), David G. Beer(University of Michigan–Ann Arbor), Robert C. Bertheau(VA Boston Healthcare System), Raj K. Goyal(VA Boston Healthcare System), Robert J. Shmookler Reis(Central Arkansas Veterans Healthcare System), Ramesh B. Batchu(Wayne State University), Rouba Ali‐Fehmi(University of Michigan)
Oncogene
March 21, 2011
10.1038/onc.2011.83
Cited by 63

Related Papers

Signatures of mutational processes in human cancer
|Nature|2013|10.1k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
|The Lancet|2021|1.7k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k